OSI Pharmaceuticals to Present at the Canaccord Adams 2009 Diabetes and Obesity Conference on Tuesday, May 12, 2009
May 07 2009 - 9:00AM
Business Wire
OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) announced today that
Dr. Anker Lundemose, Executive Vice President, OSI Pharmaceuticals
will present at the Canaccord Adams Conference in New York, NY on
Tuesday, May 12, 2009 at 8:40a.m. (Eastern Time). Dr. Lundemose
will provide an overview on the Company�s diabetes/obesity product
portfolio and business developments.
The presentation will be webcast live and may be accessed by
visiting OSI�s website at www.osip.com. A replay of the webcast
will also be available on the Company�s website until May 26,
2009.
About OSI
Pharmaceuticals
OSI Pharmaceuticals is committed to "shaping medicine and
changing lives" by discovering, developing and commercializing
high-quality, novel and differentiated personalized medicines
designed to extend life and improve the quality of life for
patients with cancer and diabetes/obesity. For additional
information about OSI, please visit http://www.osip.com.
This news release contains forward-looking statements. These
statements are subject to known and unknown risks and uncertainties
that may cause actual future experience and results to differ
materially from the statements made. Factors that might cause such
a difference include, among others, OSI's and its collaborators'
abilities to effectively market and sell Tarceva and to expand the
approved indications for Tarceva, OSI�s ability to protect its
intellectual property rights, safety concerns regarding Tarceva,
competition to Tarceva and OSI�s drug candidates from other
biotechnology and pharmaceutical companies, the completion of
clinical trials, the effects of FDA and other governmental
regulation, including pricing controls, OSI's ability to
successfully develop and commercialize drug candidates, and other
factors described in OSI Pharmaceuticals' filings with the
Securities and Exchange Commission.
Osi Pharmaceuticals (NASDAQ:OSIP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Osi Pharmaceuticals (NASDAQ:OSIP)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Osi Pharmaceuticals Inc. (MM) (NASDAQ): 0 recent articles
More OSI Pharmaceuticals, Inc. News Articles